...
首页> 外文期刊>Brain tumor pathology >Clinicopathological characteristics of circumscribed high-grade astrocytomas with an unusual combination of BRAF V600E, ATRX, and CDKN2A/B alternations
【24h】

Clinicopathological characteristics of circumscribed high-grade astrocytomas with an unusual combination of BRAF V600E, ATRX, and CDKN2A/B alternations

机译:具有不寻常组合BRAF V600E,ATRX和CDKN2A / B替代方法的临床病理学特征

获取原文
获取原文并翻译 | 示例
           

摘要

We report four cases of high-grade astrocytoma with a BRAF V600E mutation, ATRX inactivation, and CDKN2A/B homozygous deletion. Children to young adults aged 3-46 presented with a well demarcated contrast-enhancing mass in the supratentorial area. Pathological examination revealed packed growth of short spindle to round polygonal cells including some pleomorphic cells. The tumors had less ability to infiltrate into the adjacent brain parenchyma and presented a circumscribed growth pattern. Mitosis was readily found, accompanied by focal necrosis and/or microvascular proliferation. Tumors were histologically similar in part to pleomorphic xanthoastrocytoma (PXA) or anaplastic PXA, but did not fit criteria for either neoplasm. A BRAF V600E mutation and homozygous deletion of CDKN2A/B were observed, which is similar to the genetic features of PXA or epithelioid glioblastoma, but the additional loss of ATRX nuclear immunoreactivity and absence of TERT promoter mutation were unusual findings, indicating a novel genetic profile. Despite their malignant histological features, all patients had a favorable clinical course and remained alive for 6months to 28years under standard medical treatment for malignant glioma. In summary, high grade astrocytomas with BRAF V600E, ATRX, and CDKN2A/B alternations had unique clinicopathological features and may be a novel subset of high grade glioma.
机译:我们报告了四例高档星形细胞瘤,BRAF V600E突变,ATR​​X灭活和CDKN2A / B纯合缺失。孩子们到3-46岁的年轻成年人提出了透明的对比增强质量,在户外环境领域。病理检查揭示了短轴的填充生长,圆形多边形细胞,包括一些茂物细胞。肿瘤的能力较少渗入相邻的脑实质并呈现外接的生长模式。有丝分裂容易发现,伴随着局灶性坏死和/或微血管增殖。肿瘤部分地与亲属Xanthoastrocytoma(PXA)或包塑PXA组织学相似,但不符合任何一种肿瘤的标准。观察到CDKN2A / B的BRAF V600E突变和纯合缺失,其类似于PXA或上皮胶质母细胞瘤的遗传特征,但ATRX核免疫反应性和缺乏TERT启动子突变的额外丧失是不寻常的发现,表明新颖的遗传概况。尽管存在恶性组织学特征,但所有患者均有良好的临床课程,并且在恶性胶质瘤的标准治疗下,所有患者仍然活跃于6个月至28年。总之,具有BRAF V600E,ATRX和CDKN2A / B交替的高级星形细胞瘤具有独特的临床病理特征,并且可以是高级胶质瘤的新型胶质瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号